116 related articles for article (PubMed ID: 7249281)
41. Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi.
Lewis GP; Westwick J
Br J Pharmacol; 1975 Oct; 55(2):255P-256P. PubMed ID: 1201396
[No Abstract] [Full Text] [Related]
42. Platelet-surface reaction and thrombosis.
Evans G; Mustard JF
Surgery; 1968 Jul; 64(1):273-80. PubMed ID: 4173160
[No Abstract] [Full Text] [Related]
43. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
McCollum CN; Crow MJ; Rajah SM; Kester RC
Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
[TBL] [Abstract][Full Text] [Related]
44. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Hansen MS; Birgens HS
Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
[No Abstract] [Full Text] [Related]
45. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
de Gaetano G; Cerletti C; Bertelè V
Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
[No Abstract] [Full Text] [Related]
46. Microbubble elimination during priming improves biocompatibility of membrane oxygenators.
Osada H; Ward CA; Duffin J; Nelems JM; Cooper JD
Am J Physiol; 1978 May; 234(5):H646-52. PubMed ID: 645932
[TBL] [Abstract][Full Text] [Related]
47. Blood platelets and extracorporeal circulation; kinetic studies on dogs on cardiopulmonary bypass.
de Leval MR; Hill JD; Mielke CH; Macur F; Gerbode F
J Thorac Cardiovasc Surg; 1975 Jan; 69(1):144-51. PubMed ID: 1110575
[TBL] [Abstract][Full Text] [Related]
48. The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
Mustard JF; Rowsell HC; Smythe HA; Senyi A; Murphy EA
Blood; 1967 Jun; 29(6):859-66. PubMed ID: 6029001
[No Abstract] [Full Text] [Related]
49. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
Haas S; Ketterl R; Blümel G
Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
[TBL] [Abstract][Full Text] [Related]
50. Sulphinpyrazone prevents in vivo the inhibitory effect of aspirin on rat platelet cyclo-oxygenase activity.
Rajtar G; Cerletti C; Livio M; de Gaetano G
Biochem Pharmacol; 1981 Oct; 30(20):2773-6. PubMed ID: 6797431
[No Abstract] [Full Text] [Related]
51. Mode of action of currently used antiplatelet drugs.
de Gaetano G; Bertele' V; Cerletti C
Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
[No Abstract] [Full Text] [Related]
52. Platelet tests and antiplatelet drugs in coronary artery disease.
de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E
Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921
[TBL] [Abstract][Full Text] [Related]
53. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
[TBL] [Abstract][Full Text] [Related]
54. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
[TBL] [Abstract][Full Text] [Related]
55. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
Clarke RJ; Mayo G; Price P; FitzGerald GA
N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
[TBL] [Abstract][Full Text] [Related]
56. An in vitro method for platelet morphological studies employing a reconstituted collagen substrate.
Albert EN; Daniel RE; Whiting JD; Bailey JM
Scan Electron Microsc; 1979; (3):131-8. PubMed ID: 392702
[No Abstract] [Full Text] [Related]
57. Deposition of human labeled platelets to damaged rabbit aorta before and after use of sulfinpyrazone in patients with acute myocardial infarction.
Jaeger S; Berntsen H
Haemostasis; 1980; 9(5):257-62. PubMed ID: 7409611
[TBL] [Abstract][Full Text] [Related]
58. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
[TBL] [Abstract][Full Text] [Related]
59. [Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone].
Gastpar H
Fortschr Med; 1978 Sep; 96(36):1823-7. PubMed ID: 700559
[TBL] [Abstract][Full Text] [Related]
60. [Pharmacology of anti-platelet agents].
Lecompte T; Kher A; Gaillard JL; Samama M
J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
